Researchers provide prospective on low-dose radiation biology controversy

A review of the current issues in low-dose radiation research authored by two radiation biologists from the Pacific Northwest National Laboratory is the cover story of the May 2013 issue of Radiation Research. The review, by Laboratory Fellow Dr. William F. Morgan and retired PNNL scientist Dr. William J. Bair, highlights critical areas of controversy in low-dose radiation biology, and suggests areas of future research to address these issues.

In "Issues in Low Biology: The Controversy Continues. A Perspective," the authors reiterate that exposure to ionizing radiation, both natural and man-made, is a fact of life. The Fukushima disaster in 2011; the debate over the future of nuclear power; and the increasing use of radiation in medicine, agriculture, the military, national security, research, and industry has focused attention on health and safety issues associated with potential exposures to low-dose, low-dose-rate ionizing radiation.

The of the article is interested investigators. However, Morgan and Bair believe it will help government regulators, policy makers, and funding agencies understand why this is a critical time to address concerns associated with low-dose radiation exposures and the nations ability to deal with them in a rational, scientifically based manner.

More information: Morgan WF and WJ Bair. 2013. Issues in Low Dose Radiation Biology: The Controversy Continues. A Perspective. Radiation Research 179, 501-510. DOI: 10.1667/RR3306.1

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Endogenous hormones improve breast cancer risk models

17 hours ago

(HealthDay)—Inclusion of endogenous hormones in prediction models improves prediction of invasive breast cancer risk in postmenopausal women, according to a study published online Aug. 18 in the Journal of ...

Novel oncogenic RET mutation found in small cell lung cancer

18 hours ago

For the first time an oncogenic somatic mutation at amino acid 918 in the RET (rearranged during transfection) protein has been identified in small cell lung cancer (SCLC) tumors and enforced expression of this mutation within ...

User comments